Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Selecta Biosciences
AddedFeb 15, 2024
UpdatedJun 28, 2026
Selecta Biosciences

Selecta Biosciences

Public

US-based Selecta Biosciences develops nanoparticle immunomodulatory drugs for disease treatment and prevention.

HQ
Watertown, MA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Selecta Biosciences is a biopharmaceutical company focused on developing nanoparticle immunomodulatory drugs for treating and preventing human diseases. Founded in 2008 and headquartered in Watertown, Massachusetts, the company leverages its proprietary product platform technology, which combines advanced immunobiology with nanotechnology to create targeted immunomodulatory nanoparticles.

The company's innovative approach aims to address unmet medical needs by harnessing the power of nanoparticle-based therapies. Selecta Biosciences' work represents a significant step forward in the field of immunotherapy, potentially offering new treatment options for various diseases and contributing to the advancement of precision medicine.

Selecta Biosciences - Similar Companies

Cleveland BioLabs logo

Cleveland BioLabs

Imunon logo

Imunon

imunon.com

Nantkwest logo

Nantkwest

MacroGenics logo

MacroGenics

macrogenics.com

NantBio logo

NantBio

NightHawk Biosciences logo

NightHawk Biosciences

AIM Immunotech logo

AIM Immunotech

aimimmuno.com

HI-Bio logo

HI-Bio

hibio.com

ImmuneXcite logo

ImmuneXcite

Selection logo

Selection

Arytha Biosciences logo

Arytha Biosciences

arythabio.com

Cello Therapeutics logo

Cello Therapeutics

cellothera.com

Advanced NanoTherapies logo

Advanced NanoTherapies

Provenance Biopharmaceuticals logo

Provenance Biopharmaceuticals

provenancebio.com

Cour Pharmaceuticals Development logo

Cour Pharmaceuticals Development

courpharma.com

Selecta Biosciences - Quick Facts

Who are Selecta Biosciences' competitors?

Companies similar to Selecta Biosciences include Cleveland BioLabs, Imunon, Nantkwest and MacroGenics.

When was Selecta Biosciences founded?

Selecta Biosciences was founded in 2008.

Where is Selecta Biosciences' headquarters located?

Selecta Biosciences' headquarters is located in Watertown, MA, US.

When was Selecta Biosciences' last funding round?

Selecta Biosciences' most recent funding round was for $60.3M (USD) in November 2023.

How much has Selecta Biosciences raised to-date?

As of Nov 13, 2023, Selecta Biosciences has raised a total of $380.5M (USD).

How many employees does Selecta Biosciences have?

Selecta Biosciences has 75 employees as of Feb 4, 2024.

Selecta Biosciences - Classification

Ownership
  • Public
Technology
  • Biotech
  • Nanotechnology
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Immunomodulatory Drugs
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 6419Other monetary intermediation
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 520000Finance and Insurance
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 522000Credit Intermediation and Related Activities
  • 623000Nursing and Residential Care Facilities
  • 522100Depository Credit Intermediation
  • 325410Pharmaceutical and Medicine Manufacturing
  • 522110Commercial Banking
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 6000Depository Institutions
  • 8000Health Services
  • 2830Drugs
  • 6020Commercial Banks
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 6021National Commercial Banks
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified